- 0208 903 4819
- Weekday Hours: 10AM - 5PM
Polycystic ovarian syndrome (PCOS) is a condition in which the ovaries overproduce androgens, or
male sex hormones, which are typically seen in modest amounts in women. Numerous tiny cysts, or
sacs packed with fluid, develop in the ovaries and are referred to as polycystic ovaries.
PCOS, or polycystic ovarian syndrome, is thought to impact 7-8% of women who are fertile. Worldwide,
up to 70% of afflicted women go undetected.
Girls and women with PCOS are troubled with excessive facial hair, irregular periods and infertility when
they are young. As they grow older they are more prone to develop type 2 diabetes, heart attack and stroke.
Girls and women with PCOS gain weight and also struggle to lose weight.
Several studies have shown that weight loss helps to improve the hormonal profile and symptoms associated
with PCOS. Weight reduces acne and facial hair. In addition the risk of infertility and type 2 diabetes is reduced.
Polycystic ovarian syndrome (PCOS) is a condition in which the ovaries overproduce androgens, or male sex hormones, which are typically seen in modest amounts in women. Numerous tiny cysts, or sacs packed with fluid, develop in the ovaries and are referred to as polycystic ovaries.
PCOS, or polycystic ovarian syndrome, is thought to impact 7-8% of women who are fertile. Worldwide, up to 70% of afflicted women go undetected.
Girls and women with PCOS are troubled with excessive facial hair, irregular periods and infertility when they are young. As they grow older they are more prone to develop type 2 diabetes, heart attack and stroke.
Girls and women with PCOS gain weight and also struggle to lose weight.
Several studies have shown that weight loss helps to improve the hormonal profile and symptoms associated with PCOS. Weight reduces acne and facial hair. In addition the risk of infertility and type 2 diabetes is reduced.
Wegovy may be useful in managing women with PCOS weight gain. After the doctor reviews the patient in a consultation, it will determine if the patient is suitable to use the medication. The patient would start on the starter dose of 0.25mg if approved for Wegovy.
Wegovy may be useful in managing women with PCOS weight gain. After the doctor reviews the patient in a consultation, it will determine if the patient is suitable to use the medication. The patient would start on the starter dose of 0.25mg if approved for Wegovy.
Semaglutide, a medication for type 2 diabetes, is marketed under the name Wegovy. Semaglutide are members of
the glucagon-like peptide-1 (GLP-1) receptor agonist drug class. These drugs imitate the functions of the GLP-1 hormone, which aids in controlling body weight, food consumption, and hunger. By slowing down the time it takes to digest the food consumed, it makes the person feel fuller for longer which in turn reduces food intake. This
accompanied with a healthy lifestyle will lead to successful weight loss outcomes.
Research indicates that semaglutide therapy, even at low dosages, considerably lowers body weight in nearly 80% of obese PCOS patients who did not respond to a prior lifestyle modification. It is frequently linked to the menstrual cycle returning to normal, and these significant outcomes are attained with very little adverse effects.
Research indicates that semaglutide therapy, even at low dosages, considerably lowers body weight in nearly 80% of obese PCOS patients who did not respond to a prior lifestyle modification. It is frequently linked to the menstrual cycle returning to normal, and these significant outcomes are attained with very little adverse effects.
Read our articles on Wegovy & Mounjaro if you would like to learn more about the benefits, the research and case studies.
Videos created by our chief doctor on managing and understanding Wegovy to help you achieve the best outcomes possible.
Book an Appointment Today
All consultations and prescriptions are carried out by GMC registered medical practitioners.
All dispensing and shipping of medicines are completed by a UK licensed, GPhC registered Pharmacy no: 9011284.
CloudRx is our partner pharmacy and prescribing service.
*Disclaimer: Results may vary from person to person depending on individual engagement and commitment to the programme.
The content of this website is provided for general informational purposes only and is not intended as, nor should it be considered a substitute for, professional medical advice. Do not use the information on this website for diagnosing or treating any medical or health related condition. If you have or suspect you have a medical problem, promptly contact your healthcare provider.
© 2023 The London Obesity Clinic
